Skip to Main Content

Paper Details

Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer.
Oncotarget
25
2017
Author NameAffiliation
Farhad Ghasemi
Morgan Black
Morgan Black
Frederick S VizeacoumarLunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Nicole Pinto
Nicole Pinto
Kara M Ruicci
Kara M Ruicci
Matthew R LowerisonWestern University
Matthew R LowerisonRobarts Research Institute, Western University
Hon S LeongSchulich School of Medicine, Western University
Hon S LeongLawson Health Research Institute
John Yoo
John Yoo
Kevin Fung
Kevin Fung
Stephanie Danielle MacNeil
Stephanie Danielle MacNeil
David A Palma
Eric Winquist
Joe S Mymryk
Joe S Mymryk
Joe S MymrykUniversity of Western Ontario
Paul C BoutrosOntario Institute of Cancer Research
Paul C BoutrosUniversity of Toronto
Alessandro DattiLunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
John W Barrett
John W Barrett
Anthony C Nichols
Anthony C Nichols
  • 1 - 30

Datasets

Release 1.2